© 2022 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
CRANBURY, N.J.--(BUSINESS WIRE)--CURE® Media Group, the nation’s leading digital and print media enterprise dedicated to patients and survivors of cancer, was honored with four Digital Health Awards®, a competition that recognizes the world’s best digital health resources.
Winning contributions for the Spring 2018 session included:
Merit award for “A Whisper and Then a Scream” by Shannon Pulaski (CURE® Magazine);
Bronze award for “Breast Cancer Survivor Sees Red Over Pink” by Barbara Tako (CURE® Magazine);
Merit award for “Redefining Cancer” by Rick Boulay, M.D. (CURE® Magazine); and
Merit award for “Zero Tolerance: Stopping Nurse Bullying Begins with Leadership” by Sarah Handzel, BSN, RN (Oncology Nursing News®)
“We are honored to receive four Digital Health Awards® from the Health Information Resource Center, said, Michael J. Hennessy Jr, president of MJH Associates, parent company of CURE® Media Group. “These awards show the dedication and passion our editorial teams put forth each day.”
The competition — held each spring and fall — featured 80 categories. CURE® Magazine and Oncology Nursing News® were selected from more than 400 entries.
The Health Information Resource CenterSM (HIRC), organizer of the Digital Health Awards, is a national information clearinghouse for professionals who work in consumer health fields.
About CURE Media GroupCURE Media Group is the leading resource for cancer updates, research and education. It combines a full suite of media products, including its industry-leading website, curetoday.com; innovative video programs, such as CURE Connections®; a series of widely attended live events; and CURE® magazine, which reaches over 1 million readers. CURE Media Group is part of the Cranbury, New Jersey—based MJH Associates Inc. family of businesses, which includes the acclaimed OncLive® (onclive.com) platform of resources for the practicing oncologist. For more information, visit curetoday.com or mjhassoc.com.ContactsCURE Media Group Press:Theresa Burek, 609-325-4811tburek@mjhassoc.com
FDA Approves Tibsovo Plus Vidaza For Patients With Newly Diagnosed Acute Myeloid Leukemia
Surgery Timing May Have ‘Little Effect’ on Time to Ovarian Cancer Disease Progression
Will My Daughter Be a Triple-Positive Breast Cancer Pioneer?
Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations